TRIM21 and neoplasm: Moreover, knockout of TRIM21 sensitized tumor cells to RSL3, and this sensitization was reversed by overexpression of wild‐type TRIM21, but not the E3 ligase‐deficient or binding domain‐deficient mutant of TRIM21 (Figure 5B,E, H,K and Figure S5B,D, Supporting Information).